Edinburgh Cancer Centre

Running trials

• Recruiting

  Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial

  NCT07255066· Source

• Recruiting

  Single-Cell Sequencing Analysis of Radiation Pneumonitis Signals In Patients Treated For Cancer With Radiotherapy

  NCT06557343· Source

• Active, not recruiting

  First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer

  NCT06398743· Source

• Active, not recruiting

  A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

  NCT05608291· Phase 3· Source

• Recruiting

  A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

  NCT05384626· Phase 1/2· Source

• Recruiting

  A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  NCT05006716· Phase 1/2· Source

• Recruiting

  A Study of BGB-11417 in Participants With Myeloid Malignancies

  NCT04771130· Phase 1/2· Source

• Active, not recruiting

  A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

  NCT04478279· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Childhood cancers1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Colorectal cancer1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Follicular lymphoma1 recruiting
• Mantle cell lymphoma1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers

  NCT04750109· Source

• Completed

  Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

  NCT04260126· Phase 2· Source